GENETIC ENGINEERING & BIOTECHNOLOGY NEWS

Lonza agreed to buy a sterile drug product fill & finish facility from Novartis. The closing is expected to take place within the coming months....

BioNTech was welcomed by its African partners as it formally began construction on the first local mRNA vaccine manufacturing facility. Located...

Freeze-drying is the benchmark technology for drying vaccines and other biotherapeutics. However, it is expensive, time-consuming, and...

The lucrative cell and gene therapy (CGT) market is poised for dramatic growth that will likely drive revenues to nearly $37 billion/year by...

The concentration of biomanufacturing expertise in industrial nations left low- and middle-income countries with few ways to obtain the COVID-19...

The debate over whether and how broadly to approve additional “booster” doses of COVID-19 vaccines is expected to play out this month. This much...

Sponsored content brought to you by The concept of gene therapy arose initially during the 1960s and early 1970s. Turning that concept into a...

Single-Use Fluoropolymer Bag Mitigates Risk in Frozen Bioprocess Applications The promise of single-use technologies is still being unveiled....

Last February BiosanaPharma received approval from the Australian Bellberry Human Research Ethics Committee to begin a Phase I clinical trial...

Vaccine science has come a long way since the 18th century, when Edward Jenner used pus from a milkmaid’s sore to stop a child from catching...